3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
15
Small Cell Lung Carcinoma
10
Carcinoma, Hepatocellular
9
Lung Neoplasms
8
Colorectal Neoplasms
7
Neoplasms
6
Prostatic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Renal Cell
4
Breast Neoplasms
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Sarcoma
3
Neoplasm Metastasis
3
Melanoma
3
Small Cell Lung Cancer Extensive Stage
2
Ovarian Neoplasms
2
Mesothelioma, Malignant
2
Liver Neoplasms
2
Extensive Stage Lung Small Cell Carcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Interventions
pembrolizumab
29
Paclitaxel
13
Carboplatin
11
Cisplatin
10
Pemetrexed
6
lenvatinib
5
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
4
Capecitabine
4
Albumin-Bound Paclitaxel
4
patritumab deruxtecan
3
olaparib
3
Leucovorin
3
Acetaminophen
3
130-nm albumin-bound paclitaxel
3
belzutifan
2
Levoleucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Etoposide
2
Docetaxel
2
Dexamethasone
2
Cetuximab
2
Bevacizumab
2
Axitinib
2
zanidatamab
1
trifluridine tipiracil drug combination
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
atezolizumab
×
30 days
×
Clear all
No trials found.